Title of article :
What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
Author/Authors :
Judy Savige، نويسنده , , Wendy Pollock، نويسنده , , Michelle Trevisin، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2005
Pages :
14
From page :
263
To page :
276
Abstract :
Antineutrophil cytoplasmic antibodies (ANCA) are autoantibodies directed against antigens found in the cytoplasmic granules of neutrophils and monocytes. ANCA testing is usually performed to help diagnose or exclude Wegenerʹs granulomatosis and microscopic polyangiitis. The three most commonly used assays are indirect immunofluorescence (IIF) and the direct and ‘capture’ enzyme-linked immunosorbent assays (ELISAs) for ANCA directed against proteinase 3 (PR3) and myeloperoxidase (MPO). Although the International Consensus Statement for Testing and Reporting ANCA recommends that all sera are screened for ANCA by IIF and that IIF-positivity is confirmed by direct ELISAs, some laboratories test by direct ELISA alone, others screen with direct ELISA and confirm positive sera by IIF, and a few use capture ELISAs. This chapter discusses the various forms of vasculitis associated with ANCA, the usefulness of each of the ANCA assays and how ANCA testing can be used in the management of patients with small-vessel vasculitis.
Keywords :
proteinase 3 , indirect immunofluorescence , Wegener’s granulomatosis , microscopic polyangiitis , small-vessel vasculitis , antineutrophil cytoplasmic antibodies (ANCA) , neutrophil-specific antibodies , direct ELISA , capture ELISA , myeloperoxidase.
Journal title :
Best Practice and Research Clinical Rheumatology
Serial Year :
2005
Journal title :
Best Practice and Research Clinical Rheumatology
Record number :
467116
Link To Document :
بازگشت